Marketing-authorisation holder · Ireland
Leo Laboratories Limited
12 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Ireland
12 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DAIVOBET GEL | Betamethasone, Calcipotriol | Saudi Arabia | Authorised | |
| DAIVOBET GEL | Betamethasone, Calcipotriol | Saudi Arabia | Authorised | |
| DAIVOBET OINTMENT | Betamethasone, Calcipotriol | Saudi Arabia | Authorised | |
| DAIVOBET OINTMENT | Betamethasone, Calcipotriol | Saudi Arabia | Authorised | |
| Enstilar | Betamethasone, Calcipotriol | Saudi Arabia | Authorised | |
| FUCITHALMIC VISCOUS EYE DROPS | Fusidic acid | Saudi Arabia | Authorised | |
| PROTOPIC 0.03% OINTMENT | Tacrolimus | Saudi Arabia | Authorised | |
| PROTOPIC 0.03% OINTMENT | Tacrolimus | Saudi Arabia | Authorised | |
| PROTOPIC 0.1% OINTMENT | Tacrolimus | Saudi Arabia | Authorised | |
| PROTOPIC 0.1% OINTMENT | Tacrolimus | Saudi Arabia | Authorised | |
| FUCIBET 20mg/g+1mg/g crema20 mg + 1 mg · Crema | Fusidic acid, Betamethasone | Spain | Withdrawn | 2013 |
| Picato | Ingenol mebutate | EU (EMA) | Withdrawn | 2012 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 10 | 10 | 0 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Brazil, Canada, Croatia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.